Tag: CX 2025
CX 2025: Managing blood pressure with medical therapy may play a role in limiting AAA growth
Results from the Central blood pressure and variability evaluation in abdominal aortic aneurysm ...
CX 2025: Bioresorbable scaffold technology has ‘potential to be a new paradigm for femoropopliteal endovascular intervention’
In Wednesday's peripheral arterial programme, which hosted several podium-first presentations, lower...
